NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • Getting involved with research
    • Researcher Guidance
    • Post an opportunity for patient and public involvement
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

News

You are here: Home > Antimicrobial Resistance and Modernising Microbiology > Oxford medical researchers win prestigious national awards

Oxford medical researchers win prestigious national awards

14 March 2019 · Listed under Antimicrobial Resistance and Modernising Microbiology, Multimorbidity and Long-Term Conditions, Musculoskeletal, Respiratory, Stroke and Vascular Dementia, Vaccines for Emerging and Endemic Diseases

Four leading healthcare academics in Oxford have received a prestigious national award.

The University of Oxford professors have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”.

Oxford BRC Director Prof Helen McShane was among those named as an NIHR Senior Investigator

The successful candidates are all prominent researchers in the NIHR Oxford Biomedical Research Centre (BRC).

Together, the University of Oxford, Oxford Brookes University, Oxford University Hospitals NHS Foundation Trust and Oxford Health NHS Foundation Trust make up the Oxford Academic Health Science Centre (Oxford AHSC), a partnership that coordinates clinical and academic excellence across the partners.

Senior Investigators are appointed from NIHR Investigators through annual competitions, informed by the advice of an international panel of experts. In total, more than 300 Senior Investigators have now been appointed, with the number of active Senior Investigator awards maintained at around 200. They form part of the NIHR Faculty.

As well as the new appointments, three professors who had previously held awards were designated Emeritus Senior Investigators.

Among the people recognised was Prof Helen McShane, Director of the NIHR Oxford BRC. She said: “I am very proud to be one of the academics to have received this award. I’m equally proud of my university colleagues whose outstanding research leadership has been recognised with this highly competitive award.

Prof Sarah Walker

“It is a testament to the pioneering clinical research work that is being carried out in Oxford to benefit patients, as well as an endorsement of the fantastic partnership between the University of Oxford and the city’s two NHS trusts, embodied by our BRCs.”

Prof John Geddes, Director of the NIHR Oxford Health BRC, said: “These are highly prestigious awards and NIHR Senior Investigators play a leading role in delivering patient-benefiting, cutting edge research. I would like to congratulate my colleagues for achieving this national recognition. The Oxford Academic Health Science Centre now has 39 NIHR Senior Investigators, demonstrating the strength, depth and vitality of clinical research across the city.”

The new NIHR Senior Investigators are:

  • Professor Helen McShane, Director of the NIHR Oxford Biomedical Research Centre; Professor of Vaccinology, Nuffield Department of Medicine
  • Professor Ann Sarah Walker, Professor of Medical Statistics and Epidemiology, Nuffield Department of Medicine
  • Professor Matthew Costa, Professor of Orthopaedic Trauma, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
  • Professor Richard McManus, Professor of Primary Care, Nuffield Department of Primary Care Health Sciences

The new NIHR Emeritus Senior Investigators are:

  • Professor Alastair Buchan, Professor of Stroke Medicine, Radcliffe Department of Medicine (RDM)
  • Professor Ian Pavord, Professor of Respiratory Medicine, Nuffield Department of Medicine

Also named as an NIHR Emeritus Senior Investigator was Prof Rury Holman, Director of the RDM’s Diabetes Trials Unit, who was formerly associated with the NIHR Oxford BRC.

Prof Matthew Costa

The NIHR describes Senior Investigators as “among the most prominent and prestigious researchers funded by the NIHR and the most outstanding leaders of patient and people-based research within the NIHR research community.”

Each is awarded a discretionary fund of £15k per year. In addition, NHS institutions with whom Senior Investigators are associated and which are eligible for Research Capability Funding (RCF) attract an additional amount for each of their Senior Investigators.

The role of the NIHR Senior Investigator includes contributing significantly to the NIHR as a senior leader; leading in the training and development of staff; acting as an ambassador for the NIHR in the wider healthcare system; maintaining and developing a track record of excellence in clinical and applied research; contributing to economic growth; and integrating patient and public involvement and engagement into research.

← HIV remission achieved in second patient
Event showcases BRC work tackling chronic diseases →

News

  • Study highlights ongoing COVID-19 risk in some cancer patients despite vaccination 24 May 2022
  • BRC study outlines researchers training needs and barriers 20 May 2022
  • Three new Blood and Transplant Research Units created in Oxford 18 May 2022
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2022 NIHR Oxford Biomedical Research Centre